Urogen Pharma Ltd. (URGN)
Market Closed
17 Jul, 20:00
$
40. 23
+0.23
+0.575%
$
1.91B Market Cap
- P/E Ratio
- Div Yield
1.27M Volume
-3.56 Eps
$ 40
Previous Close 
Want to track URGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Urogen Pharma Ltd. (URGN) Statistics
Valuation metrics
Market Cap 1.91B
Enterprise value 2.05B
Trailing P/E (ttm) -14.63
Forward P/E 20.03
PEG ratio -1.19
Price/Sales (ttm) 13.95
Price/Book (mrq) -16.25
Enterprise Value/Revenue 14.56
Enterprise Value/EBITDA -17.67
Overview
Shares outstanding 48.35M
Float 38.71M
Shares short 7.24M
% Held by insiders 0.04%
% Held by institutions 0.98%
Average volume (10 days) 934.97K
Average volume (90 days) 925.91K
Price summary
52-Week low 14.33
52-Week high 41.88
Beta 1.59
50-Day moving average 36.96
200-Day moving average 23.36
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.95%
Operating margin -0.77%
Operational effectiveness
Return on assets -0.53%
Return on equity 1.22%
Income Statement
Revenue (ttm) 140.49M
Revenue per share (ttm) 2.8
Quarterly revenue growth (yoy) 1.52%
Gross profit (ttm) 126.24M
EBITDA -107.9M
Net income to common (ttm) -133.22M
Diluted EPS (ttm) -2.65
Quarterly earnings growth (yoy) 0.54%
Balance Sheet
Total cash (mrq) 140.27M
Total cash per share (mrq) 2.82
Total debt (mrq) 197.09M
Total Debt/Equity (mrq) -1.59
Current ratio (mrq) 4.69%
Book value per share (mrq) -2.48
Cash Flow
Cash flow statement -165.74M
Levered free cash flow (LFCF) -109.28M
